Help Your Cat Get Back to Their “Normal”

Cats hide almost everything, especially pain. But if your cat is dealing with osteoarthritis (OA) pain, you’ve probably noticed changes in their everyday behavior. Things like jumping, climbing stairs, and even playing might not be so easy for them.

Available later in 2022, Solensia is a monthly injection administered at your vet's office that can help control the pain your cat may experience from OA.

Are you missing the signs of your cat’s OA pain? Fill out our quick checklist.

Cat stretching.
Cat climbing on table

What Is Cat OA Pain?

OA is a type of arthritis that occurs when the tissue in your cat’s joints starts to get worn down, causing bones to rub against one another. You’d think this just makes moving harder, but OA can also cause severe pain. Without treatment, your cat's pain can continue to get worse.

Why Solensia?

While cat OA isn’t curable, the pain from OA can now be effectively managed.

Solensia helps your cat get back to moving more freely again and stops OA pain from disrupting the unique bond they share with you.

Solensia product package
Man with cat by sink

What to Expect With Solensia

In a clinical study, cat owners reported that Solensia improved their cat’s quality of life, comfort, and overall well-being.1

  • Controls OA pain in cats, which can lead to an easier time moving1

  • A once-monthly injection given at your vet's office

  • Works like your cat's naturally made antibodies to reduce pain signals2

Cat laying on carpet

Vet-Approved Support

Solensia FAQ

IMPORTANT SAFETY INFORMATION: See full Prescribing Information. For use in cats only. Women who are pregnant, trying to conceive or breastfeeding should take extreme care to avoid self-injection. Allergic reactions, including anaphylaxis, could potentially occur with self-injection. Solensia should not be used in breeding cats or in pregnant or lactating queens. Solensia should not be administered to cats with known allergy to frunevetmab. The most common adverse events reported in a clinical study were vomiting and injection site pain.

INDICATION: For the control of pain associated with osteoarthritis in cats.

*67% of cat owners experienced improvement in signs of their cat’s pain in the placebo group.

References:

  1. Gruen ME, Myers JAE, Lascelles BDX. Efficacy and safety of an anti-nerve growth factor antibody (frunevetmab) for the treatment of degenerative joint disease-associated chronic pain in cats: a multisite pilot field study. Front Vet Sci. 2021;8:610028. doi:10.3389/fvets.2021.610028
  2. Keizer RJ, Huitema AD, Schellens JH, Beijnen JH. Clinical pharmacokinetics of therapeutic monoclonal antibodies. Clin Pharmacokinet. 2010;49(8):493-507. doi:10.2165/11531280
  3. Solensia (frunevetmab injection). Package insert. Zoetis Inc; 2022.

SLN-00070